ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LXRX Lexicon Pharmaceuticals Inc

1.64
-0.05 (-2.96%)
May 29 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,786,517
Bid Price 1.63
Ask Price 1.69
News (1)
Day High 1.69

Low
0.92

52 Week Range

High
3.73

Day Low 1.63
Company Name Stock Ticker Symbol Market Type
Lexicon Pharmaceuticals Inc LXRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -2.96% 1.64 18:26:52
Open Price Low Price High Price Close Price Prev Close
1.67 1.63 1.69 1.64 1.69
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,565 1,786,517 $ 1.66 $ 2,962,108 - 0.92 - 3.73
Last Trade Time Type Quantity Stock Price Currency
19:56:28 4 $ 1.69 USD

Lexicon Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
404.13M 244.92M - 1.2M -177.12M -0.72 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Lexicon Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LXRX Message Board. Create One! See More Posts on LXRX Message Board See More Message Board Posts

Historical LXRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.681.7351.5851.641,837,578-0.04-2.38%
1 Month1.592.041.511.742,661,9320.053.14%
3 Months2.272.82911.482.113,509,649-0.63-27.75%
6 Months1.123.731.042.103,671,4370.5246.43%
1 Year3.403.730.921.983,074,372-1.76-51.76%
3 Years4.446.32990.922.411,567,586-2.80-63.06%
5 Years5.869.650.923.181,959,586-4.22-72.01%

Lexicon Pharmaceuticals Description

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of human disease. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Your Recent History

Delayed Upgrade Clock